News and Announcements

As originally published on Astellas website on October 9, 2015. Hershey, PA & Rockville, MD and Tokyo, Japan, October 9, 2015 – Immunomic Therapeutics, Inc. (“Immunomic Therapeutics”), a company developing next generation vaccines based on the LAMP-vax platform, and Astellas Pharma Inc. (“Astellas”) today announced they have entered into an exclusive worldwide license agreement to […]

October 10th, 2015

Posted In: International News, Portfolio Exits

Keiretsu Forum Northern California members that invested in Boston Heart Diagnostics (BHD) in 2009 and 2011 have received a 10x return this month.  BHD was recently acquired by Eurofins Scientific, a Luxembourg-based company, for $140 million.  This will also include an earn-out that they expect will yield another $60 million for its selling shareholders. This […]

March 5th, 2015

Posted In: Portfolio Exits

Tags: , , ,

  • Keiretsu Academy North